Answers are grounded in this paper and cite their sources.
Diagnosed but untreated chronic Hepatitis C virus infection remains an important public health problem in Los Angeles County, particularly affecting underserved and minority groups. This mixed-methods study (October 2024-January 2025) aimed to identify and describe the barriers and facilitators to accessing Hepatitis C virus treatment among Los Angeles County residents. The study used de-identified programmatic data from 344 case-residents in a linkage-to-cure program and conducted thematic analysis of semi-structured interviews with ten participants (seven untreated, three treated) from the linkage-to-cure program. Overall, 54% of case-residents reported experiencing barriers. Among those reporting specific barriers (n = 91), personal barriers were most common (43%), followed by provider-related barriers (31%), insurance barriers (13%), and inadequate access to medical care (13%). Interviews provided further context. Themes identified included homelessness, incarceration, and drug addiction as key personal barriers. Provider-related barriers included language barriers, expressed frustration in navigating the healthcare system, long wait times to see a provider, and participants’ lack of HCV information. Insurance barriers were characterized by cost barriers and inadequate access to medical care due to a lack of transportation. Facilitators of treatment access included personal motivation to seek treatment, family and community-based support systems, trust in their medical provider, adequate insurance coverage, understanding the benefits of HCV treatment, and the desire to avoid stigmatization. Local efforts to eliminate Hepatitis C should consider equitable interventions that address individual and system-level barriers. Potential strategies include implementing language support services, leveraging patient navigation and care coordination services, utilizing mobile clinics for the unhoused, ensuring treatment continuity for people re-entering the community from incarceration, and removing insurance restrictions, such as prior authorization requirements.
No takes yet. Share an insight, caveat, or question.
Handa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: